The Valley Desk

ArticlePediatric blood & cancerPublished

Long-term follow-up of patients with intermediate-risk neuroblastoma treated with response- and biology-based therapy: A report from the Children's Oncology Group study ANBL0531

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Pediatric blood & cancer
Published
Subject terms
Humans; Neuroblastoma; Antineoplastic Combined Chemotherapy Protocols; Neoplasm Staging; Prognosis; Survival Rate; Follow-Up Studies; Adolescent; Child; Child, Preschool; Infant; Infant, Newborn
PubMed ID
38822537
PubMed Central ID
PMC11318088
Added to directory
Source checked

Report a correction or request removal